LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
AEMD Aethlon Medical
- 0.6056
- +0.0180+3.06%
Close Dec 27 16:00 ET
- 0.5904
- -0.0152-2.51%
Post 19:59 ET
8.46MMarket Cap-0.22P/E (TTM)
0.6500High0.5587Low3.10MVolume0.6202Open0.5876Pre Close1.89MTurnover22.35%Turnover RatioLossP/E (Static)13.96MShares2.289952wk High1.41P/B8.39MFloat Cap0.237552wk Low--Dividend TTM13.86MShs Float67499.9865Historical High--Div YieldTTM15.54%Amplitude0.2375Historical Low0.6100Avg Price1Lot Size
Aethlon Medical Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 18.11%-2.21M | 29.60%-1.75M | 3.57%-10.13M | 12.94%-2.57M | -21.87%-2.38M | 6.05%-2.7M | 9.03%-2.48M | -7.56%-10.51M | 4.92%-2.95M | 28.22%-1.95M |
| Net income from continuing operations | 7.50%-2.81M | 21.65%-2.57M | -1.48%-12.21M | 1.68%-2.43M | -21.72%-3.47M | 20.34%-3.03M | -12.94%-3.28M | -15.44%-12.03M | 34.84%-2.47M | -12.65%-2.85M |
| Operating gains losses | ---- | ---- | -85.13%21.14K | --17.86K | ---- | ---- | ---- | --142.12K | --0 | --0 |
| Depreciation and amortization | -6.13%85.83K | -4.72%86.06K | 49.05%359.06K | 7.91%85.83K | 17.08%91.47K | 73.90%91.43K | 194.70%90.33K | 94.76%240.89K | 214.12%79.54K | 342.06%78.13K |
| Other non cash items | 20,348.54%140.28K | -198.30%-1.22K | -99.41%143 | -218.77%-1.22K | -104.12%-566 | -62.58%686 | -84.13%1.24K | -20.06%24.41K | -95.09%1.02K | 15.59%13.75K |
| Change In working capital | 1,431.75%252.82K | 30.91%599.73K | 632.58%478.66K | 53.50%-381.63K | -22.31%421.15K | -104.51%-18.98K | 697.10%458.12K | 126.02%65.34K | -299.14%-820.66K | 228.83%542.08K |
| -Change in receivables | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 505.98%127.97K | --0 | --114.85K |
| -Change in prepaid assets | 112.84%202.2K | -38.62%89.87K | -102.57%-10.23K | -355.34%-292.42K | -62.86%40.78K | 27.49%95K | 47.39%146.41K | 162.54%398.17K | 141.97%114.52K | 123.74%109.79K |
| -Change in payables and accrued expense | 144.41%50.62K | 63.57%509.86K | 520.56%488.89K | 75.29%-89.2K | 19.82%380.37K | -149.29%-113.99K | 202.53%311.71K | -186.26%-116.25K | -163.75%-360.94K | 534.55%317.44K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -250.00%-344.55K | -600.00%-574.25K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 18.11%-2.21M | 29.60%-1.75M | 3.57%-10.13M | 12.94%-2.57M | -21.87%-2.38M | 6.05%-2.7M | 9.03%-2.48M | -7.56%-10.51M | 4.92%-2.95M | 28.22%-1.95M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 73.40%-250.87K | 56.53%-4.91K | 94.19%-8.81K | 99.08%-6.77K | -459.60%-230.38K | -170.08%-943.11K | 94.68%-11.29K | -161.48%-151.49K |
| Net PPE purchase and sale | --0 | --0 | 73.40%-250.87K | 56.53%-4.91K | 94.19%-8.81K | 99.08%-6.77K | -459.60%-230.38K | -170.08%-943.11K | 94.68%-11.29K | -161.48%-151.49K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 73.40%-250.87K | 56.53%-4.91K | 94.19%-8.81K | 99.08%-6.77K | -459.60%-230.38K | -170.08%-943.11K | 94.68%-11.29K | -161.48%-151.49K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 61.07%-3.83K | 399.12%5.38M | -85.56%1.29M | 1,715.02%42.57K | 9,501.75%177.13K | -100.12%-9.84K | 73.99%1.08M | -48.67%8.91M | 75.23%-2.64K | 86.10%-1.88K |
| Net common stock issuance | --0 | 395.74%5.38M | -85.19%1.32M | --49.76K | --186.5K | --0 | 75.34%1.09M | -48.86%8.93M | --0 | --0 |
| Net other financing activities | 61.07%-3.83K | 39.35%-5.08K | -178.38%-34.78K | -172.76%-7.19K | -397.51%-9.37K | ---9.84K | ---8.37K | 85.82%-12.49K | 75.23%-2.64K | 86.10%-1.88K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 61.07%-3.83K | 399.12%5.38M | -85.56%1.29M | 1,715.02%42.57K | 9,501.75%177.13K | -100.12%-9.84K | 73.99%1.08M | -48.67%8.91M | 75.23%-2.64K | 86.10%-1.88K |
| Net cash flow | ||||||||||
| Beginning cash position | -29.46%9.16M | -62.18%5.53M | -14.80%14.62M | -54.17%8.06M | -47.88%10.26M | -13.49%12.99M | -14.80%14.62M | 73.19%17.16M | -14.13%17.59M | -15.38%19.69M |
| Current changes in cash | 18.46%-2.22M | 322.12%3.63M | -258.91%-9.09M | 14.62%-2.53M | -4.99%-2.21M | -158.11%-2.72M | 23.98%-1.64M | -134.94%-2.53M | 10.88%-2.96M | 24.56%-2.1M |
| Effect of exchange rate changes | 581.99%5.09K | -593.55%-1.29K | 135.37%2.11K | 62.11%-2.26K | --5.61K | ---1.06K | ---186 | ---5.96K | ---5.96K | --0 |
| End cash Position | -32.32%6.95M | -29.46%9.16M | -62.18%5.53M | -62.18%5.53M | -54.17%8.06M | -47.88%10.26M | -13.49%12.99M | -14.80%14.62M | -14.80%14.62M | -14.13%17.59M |
| Free cash flow | 18.31%-2.21M | 35.58%-1.75M | 9.33%-10.38M | 13.11%-2.57M | -13.51%-2.39M | 25.06%-2.71M | 2.07%-2.71M | -13.17%-11.45M | 10.67%-2.96M | 24.26%-2.1M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |